Exoskeletal assisted walking devices currently do not demonstrate …
WEBSep 14, 2024 · 1. In veterans with spinal cord injuries, exoskeletons showed no clear benefits (medical, physical or psychological) compared to standard wheelchair use 2. Exoskeleton technology is still not adopted readily with participants only using the devices an average of 86 minutes per week Evidence Rating Level: 1 (Excellent) Spinal cord injuries (SCI) often result in severe
Home | 2 Minute Medicine
WEB2 Minute Medicine Rewind September 16, 2024. by Jayden Berdugo and 1 others. September 16, 2024. Sleep patterns, physical activity, genetic susceptibility, and incident rheumatoid arthritis: a prospective cohort study 1. In this prospective cohort study, a healthy sleep pattern and moderate levels of physical activity...
The RACE-II trial: Lenient vs. strict rate-control in atrial ...
WEBSep 22, 2014 · 1. Lenient rate-control was found to be non-inferior to strict rate-control in managing patients with atrial fibrillation. 2. Compared to strict rate-control, lenient rate-control could be achieved with lower doses of medication and fewer medications. Original Date of Publication: April 15, 2010 Study Rundown: Atrial fibrillation is the most prevalent sustained cardiac arrhythmia.
The ARMA trial: Lower tidal volume ventilation in ALI/ARDS …
WEB1. The trial was terminated early when the data demonstrated that lower tidal volume ventilator settings in ALI/ARDS patients led to a significant decrease in in-hospital mortality. 2. Low tidal volume ventilation also led to an increase in ventilator-free days and a decrease in the number of days with systemic organ failure. There was no.
Landmark Trials & Summaries: The Classics in Medicine - 2 Minute …
WEBA deep understanding of these trials is paramount for every physician, healthcare professional, and trainee, as it lays the foundation for evidence-based clinical decisions made daily. 2MM+ Subscriber Exclusive Access: The Online Edition of The Classics Series™ includes The Classics in Medicine™ textbook and all deep-dive sub-specialty ...
The RAVE trial: Rituximab for ANCA-associated vasculitis [Classics ...
WEBJun 23, 2013 · Image: PD 1. Rituximab is non-inferior to cyclophosphamide in inducing remission of severe ANCA-associated vasculitis. 2. There were no significant differences between the two groups in the rate of total, serious, or non-disease-related adverse events. Original Date of Publication: July 15, 2010 Study Rundown: The combination of cyclophosphamide and glucocorticoid has long been the standard
Biguanides and dipeptidyl peptidase-4 inhibitors use have similar ...
WEBAug 16, 2024 · 1. Biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors show no differences in major cardiac or cerebrovascular events, diabetic complications, or death in the Japanese population. Evidence Rating Level: 2 (Good) The initial pharmacologic intervention for type 2 diabetes mellitus (T2DM) includes biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors.
The SAFE trial: Normal saline vs. albumin for fluid resuscitation ...
WEBSep 22, 2014 · 1. There was no significant difference in 28-day mortality when comparing albumin and normal saline for fluid resuscitation in the intensive care setting. 2. Compared to normal saline, fluid resuscitation with albumin did not yield any significant benefits in terms of secondary outcomes (i.e., length of ICU/hospital stay, duration of supportive treatment measures).
Biomarkers may help guide antibiotic stewardship in community …
WEBAug 26, 2024 · 1. Using either procalcitonin or c-reactive protein as a biomarker to guide antibiotic treatment in patients with community-acquired pneumonia reduces the length of treatment course with no effect to time to reach stability or new antibiotic prescriptions Evidence Rating Level: 1 (Excellent) 20-50% of the 3.3 million people who develop community-acquired pneumonia (CAP) need to
Mediterranean diet effects on vascular health and serum levels of ...
WEBAug 15, 2024 · 1. The effect of the Mediterranean Diet on cardiovascular health can be partially explained by improved vascular health, lowered total cholesterol and LDL, lowered ceramides, and reduced serum inflammatory adipokines. Evidence Rating Level: 1 (Excellent) Study Rundown: The Mediterranean Diet has been previously shown to improve cardiovascular outcomes in patients.
Skip to content